Kyle Haraldsen

Kyle Haraldsen has extensive experience in the pharmaceutical industry, with their most recent position being the Chief Technology Officer at Lyndra Therapeutics. Prior to that, they worked as a Principal at KBH Consulting Group. Kyle also served as the Chief Technical Operations Officer at Saniona and was responsible for overseeing technical operations, including portfolio governance, risk assessment, program management, and clinical supply operations. At AMAG Pharmaceuticals, Kyle held various roles, including VP of Technical Operations & Project Management, VP of Technical Operations, and Senior/Executive Director of Technical Operations. In these roles, they led the supply chain and technical operations for multiple commercial and development products, managed key products, and played a crucial role in the development and filing of regulatory applications. Earlier in their career, they were a Senior Director of Manufacturing at Radius Health, Inc. and a Director of External Manufacturing at AMAG Pharmaceuticals, where they focused on program management, financial management, and regulatory compliance. Kyle is experienced in strategic planning, team management, program design, and leadership in the pharmaceutical industry.

Kyle Haraldsen attended Northeastern University, where they pursued a Bachelor of Science degree in Chemical Engineering. No specific dates or completion year were provided for their education at Northeastern University.